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OBJECTIVE—Fetal malnutrition may predispose to type 2
diabetes through gene programming and developmental changes.
Previous studies showed that these effects may be modulated
by genetic variation. Genome-wide association studies discov-
ered and replicated a number of type 2 diabetes–associated
genes. We investigated the effects of such well-studied poly-
morphisms and their interactions with fetal malnutrition on
type 2 diabetes risk and related phenotypes in the Dutch
Famine Birth Cohort.
RESEARCH DESIGN AND METHODS—The rs7754840 (CD-
KAL1), rs10811661 (CDKN2AB), rs1111875 (HHEX), rs4402960
(IGF2BP2), rs5219 (KCNJ11), rs13266634 (SLC30A8), and
rs7903146 (TCF7L2) polymorphisms were genotyped in 772
participants of the Dutch Famine Birth Cohort Study (n  328
exposed, n  444 unexposed). Logistic and linear regression
models served to analyze their interactions with prenatal expo-
sure to famine on type 2 diabetes, impaired glucose tolerance
(IGT), and area under the curves (AUCs) for glucose and insulin
during oral glucose tolerance testing (OGTT).
RESULTS—In the total population, the TCF7L2 and IGF2BP2
variants most strongly associated with increased risk for type 2
diabetes/IGT and increased AUC for glucose, while the CDKAL1
polymorphism associated with decreased AUC for insulin. The
IGF2BP2 polymorphism showed an interaction with prenatal
exposure to famine on AUC for glucose ( 9.2 [95% CI 16.2
to 2.1], P  0.009).
CONCLUSIONS—The IGF2BP2 variant showed a nominal in-
teraction with exposure to famine in utero, decreasing OGTT
AUCs for glucose. This may provide a clue that modulation of the
consequences of fetal environment depends on an individual’s
genetic background. Diabetes 58:1440–1444, 2009
T
he fetal origins hypothesis (1,2) states that mal-
nutrition during fetal development predisposes
to adverse health outcomes, such as type 2
diabetes. According to the hypothesis, fetal ad-
aptation to a low-caloric intrauterine environment may
involve programming to optimize the use of restricted
nutrient supply. Programming may lead to altered gene
expression proﬁles and eventually to disease later in life.
In addition, adverse intrauterine circumstances may
divert nutrients to critical organs such as the brain at
the expense of organs such as the pancreas, liver, or
muscles (3).
Type 2 diabetes and defective insulin secretion show
high heritabilities (4). Genetic variation is likely to interact
with the fetal response to an extreme nutritional situation.
We found that the effects of the Pro12Ala polymorphism of
the peroxisome proliferator–activated receptor (PPAR)2
gene depend on prenatal exposure to famine (5), and
several studies (6–8) have shown interactions of genes
with size at birth, a marker of fetal environment. Such
interactions may have consequences for development and
function. Previously, the PPAR, TCF7L2, and KCNJ11
genes were identiﬁed by linkage and candidate gene
studies as type 2 diabetes risk loci (9–11). Recently,
genome-wide association studies have identiﬁed and rep-
licated new genetic variants associated with type 2 diabe-
tes (12–15). Notably, a number of these variants are
thought to be involved in the development and function of
critical organs for glucose metabolism, such as the pan-
creatic -cell (16–18).
Based on the ﬁndings described above, we hypothe-
sized that these genes interact with fetal exposure to
famine. In the Dutch Famine Birth Cohort, we investi-
gated the effects of genetic variation in these loci on
type 2 diabetes, impaired glucose tolerance (IGT), oral
glucose tolerance testing (OGTT), and their interaction
with fetal malnutrition.
RESEARCH DESIGN AND METHODS
The Dutch Famine Birth Cohort is composed of individuals born as term
singletons around the time of the Dutch famine during World War II in the
Wilhelmina Gasthuis in Amsterdam. Details of the study have been described
elsewhere (19). In brief, a total of 2,414 singletons were born between 1
November 1943 and 28 February 1947. Members of the cohort living in the
Netherlands at 1 September 2002 were invited (n  1,423). Of these, 810
agreed to participate. The study was approved by the local medical ethics
committee and was conducted in accordance with the declaration of Helsinki.
All participants gave their written informed consent.
Exposure to famine. Prenatal exposure to famine was deﬁned as a daily food
ration of the mother 1,000 calories during any 13-week period of gestation,
based on the ofﬁcial daily food rations for the general population aged 21
years. Based on these data, individuals born between 7 January 1945 and 8
December 1945 were exposed to famine in utero. Initially, we deﬁned three
exposure groups of 16 weeks, dividing the period of exposure in late, mid-, and
early gestation. However, this led to small groups in which meaningful genetic
analyses were impossible. Therefore, we combined the exposed groups for the
interaction analyses.
Study parameters. Trained research nurses conducted measurements and
interviews as previously described (19). In brief, information on medical
history, lifestyle, and medication was derived from a standardized interview.
Information on the mother, the pregnancy, and size at birth was derived from
medical birth records.
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Pre-existent diabetes was deﬁned as the use of oral or injected antidiabetes
medications. Individuals with pre-existent diabetes were excluded from
OGTT. OGTT was performed after an overnight fast with a standard load of
75 g of glucose at t  0. Blood samples were collected after 0, 30, 60, and 120
min for measurement of plasma glucose and insulin concentrations. Plasma
glucose was measured by a standardized enzymatic photometric assay on a
Modulator P analyzer (Roche, Basel, Switzerland). Plasma insulin was mea-
sured by immunoluminometric assay on an Immulite 2000 Analyzer (Diagnos-
tic Product Corporation, Los Angeles, CA). IGT was deﬁned as a 120-min
glucose level between 7.8 and 11.0 mmol/l. Diabetes based on OGTT was
deﬁned as a 120-min glucose level 11.0 mmol/l.
Genotyping. Genomic DNA was extracted from fasting blood samples. The
rs7754840 (CDKAL1), rs10811661 (CDKN2AB), rs1111875 (HHEX), rs4402960
(IGF2BP2), rs5219 (KCNJ11), rs13266634 (SLC30A8), and rs7903146
(TCF7L2) polymorphisms were genotyped with Taqman allelic discrimination
assays. The assays were designed and optimalized by Applied Biosystems
(Foster City, CA). The analyses were performed as described previously (20).
Assays were run on 90 blood bank samples to test for adequate cluster
separation. Genotypes were determined in 2 ng genomic DNA. Reactions were
performed on the Taqman Prism 7900HT platform. Success rates for genotyp-
ing ranged from 86.1% (IGF2BP2) to 96.7%. The duplicate mismatch rate for
the IGF2BP2 assay was 0. Genotyping for at least one polymorphism was
successful in 772 subjects.
Statistical methods. The primary end point was the area under the curve
(AUC) for glucose and insulin during OGTT. A secondary combined end point
of type 2 diabetes and IGT consisted of pre-existent type 2 diabetes and type
2 diabetes and IGT identiﬁed at OGTT.
Continuous variables are expressed as means  SD. Comparisons between
groups were performed with ANOVA and 
2 tests for normally distributed
continuous and categorical variables, respectively. Logarithmic transforma-
tion was performed on variables that were not normally distributed. Allele
frequencies were estimated by gene counting. Hardy-Weinberg equilibrium
was tested by 
2 testing.
The AUCs during OGTT were calculated by the trapezoidal rule (21): {[15 	
log (gluc0min)] 
 [30 	 log (gluc30min)] 
 [45 	 log (gluc60min)] 
 [30 	 log
(gluc120min)]/120} and {[15 	 log (ins0min)] 
 [30 	 log (ins30min)] 
 [45 	
log (ins60min)] 
 [30 	 log (ins120min)]/120} for glucose and insulin,
respectively. Binary logistic and linear regression models served to inves-
tigate the associations of the genetic variants with type 2 diabetes/IGT risk
and AUC for glucose and insulin. The additive model of inheritance was
assumed.
Genotype by prenatal famine exposure interactions were tested by creating
interaction terms for each genetic variant (coded 0, 1, or 2 for carrying the risk
allele) with the exposure group (coded 0 and 1 for unexposed and exposed
subjects, respectively). Unexposed subjects were the subjects born before or
conceived after the Dutch famine. Genotype by birth weight interaction
models were created by taking the product of birth-weight (continuous)
and the genetic variant (coded 0, 1, and 2). All models were adjusted for
sex. Subsequently, models were adjusted for BMI. Additionally, waist
circumference and the mother’s parity and weight at the last antenatal visit
were added. Models investigating famine were additionally adjusted for
birth weight and vice versa. We adjusted for multiple testing by means of
Bonferroni adjustment. We had 80% power to detect interactions of 7.8
with gene and environmental 3.0 (minor allele frequency 30%, 
0.05).
RESULTS
General characteristics and population genetics. Gen-
eral and maternal characteristics of 772 genotyped indi-
viduals divided into the famine exposure groups are
shown in Table 1. Minor allele frequencies were 0.31, 0.19,
0.35, 0.29, 0.36, 0.29, and 0.30 for the CDKAL1, CDKN2A/B,
HHEX, IGF2BP2, KCNJ11, SLC30A8, and TCF7L2 poly-
morphisms,respectively.AllpolymorphismswereinHardy-
Weinberg equilibrium (
2  3.3; 2 df; P  0.07 for all
SNPs). A total of 94 individuals with type 2 diabetes (62
prevalent and 32 based on OGTT) and 100 individuals with
IGT were included in the analyses on type 2 diabetes/IGT.
For the analyses on the AUCs for glucose and insulin
during OGTT, 102 individuals were excluded from the total
population because of pre-existent diabetes, nonfasting
before the test, or incomplete results.
Associations and interactions with prenatal expo-
sure to famine on type 2 diabetes/IGT and AUCs for
glucose and insulin. Table 2 shows odds ratios (ORs) of
the genetic variants for the composite outcome type 2
diabetes/IGT and the -coefﬁcients for AUCs for glucose
and insulin during the OGTT. The TCF7L2 and IGF2BP2
variants were associated with increased type 2 diabetes/
IGT risk (TCF7L2: OR 1.39 [95% CI 1.08–1.79], IGF2BP2:
1.43 [1.11–1.85]) and increased AUC for glucose (TCF7L2:
4.5 [1.0–8.1], IGF2BP2: 3.6 [0.1–7.1]). The
CDKAL1 variant associated with a decreased AUC for
insulin ( 8.2 [16.1 to 0.41]), which became less
strong after adjustment for BMI. None of the other results
changed considerably after additional adjustments in mul-
tivariate models. None of the polymorphisms had a signif-
icant effect on birth weight or were related to prenatal
famine exposure (data not shown).
Table 3 shows the interactions between genetic vari-
ants and exposure to famine in utero. The IGF2BP2
showed a signiﬁcant interaction on AUC glucose (
interaction 9.2 [16.2 to 2.1], P  0.009). Figure 1
shows the effects of the IGF2BP2 polymorphism on AUC
TABLE 1








n 772 233 140 117 71 211
Characteristics at age 58 years
% men 45.9 46.8 44.3 39.3 42.3 50.7 NS
Age (years) 58.3  0.9 59.2 58.5 58.2 58.0 57.4 NS
BMI (kg/m
2) 28.6  4.8 28.7 28.3 28.1 28.0 29.0 NS
Waist circumference (cm) 92.7  8.9 93.3 92.9 90.8 91.9 93.2 NS
Currently smoking (%) 24.1 20.6 27.9 25.9 31.0 23.1 NS
Birth characteristics
Gestational age (days) 285  11.1 284 283 285 289 285 NS
Birth weight (g) 3,359  469 3,396 3,187 3,204 3,500 3,471 0.001
Maternal characteristics
Age at delivery (years) 28.9  6.4 28.7 31.1 28.8 27.2 28.4 NS
Primiparous (%) 33.7 36.1 20.0 33.3 42.3 37.4 0.04
Weight gain (third trimester) 2.9  2.9 2.8 0.0 4.3 5.0 3.4 0.01
Weight at last antenatal visit 66.4  8.7 66.4 62.8 63.6 69.0 69.3 0.001
Data are means  SD. *P value for comparison between exposed and nonexposed. NS, not signiﬁcant.
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Bonferroni correction for 21 tests, this was no longer
signiﬁcant. None of the polymorphisms showed a signif-
icant interaction with birth weight (data not shown).
Additional adjustments in multivariate models did not
change the results.
DISCUSSION
In the present study, we investigated interactions of type 2
diabetes–associated polymorphisms in a population ex-
posed to famine in utero. The IGF2BP2 polymorphism
showed a nominally signiﬁcant interaction with prenatal
exposure to famine on AUC for glucose during OGTT.
The Dutch Famine Birth Cohort provides a unique
opportunity to directly investigate the interactions of fetal
malnutrition with type 2 diabetes and related measure-
ments. Most studies on the association of early nutrition
with type 2 diabetes and related parameters have used
birth weight as a marker of fetal nutrition and growth.
Unfortunately, a consequent limitation is the size of our
study population, which limits the power to detect small
effects. This especially holds for the categorical outcome
type 2 diabetes/IGT. Nonetheless, effects found in the
population largely corresponded to previous literature,
except for the direction of the effect of the HHEX poly-
morphism, for which we have no explanation. This effect
disappeared after adjustment for BMI. Due to power
limitations, we were unable to investigate the interactions
with timing of exposure to famine during gestation (late,
mid-, or early gestational exposure to famine).
Several studies have identiﬁed interactions of size at
birth and genetic variants on type 2 diabetes risk and
measurements of glucose metabolism (6–8). Previously,
we reported an interaction between a PPAR gene variant
and fetal malnutrition (5). Now, we observed a nominally
signiﬁcant interaction of the IGF2BP2 polymorphisms
with exposure to famine on glucose levels during OGTT.
The effect on type 2 diabetes/IGT risk was in the same
direction but not signiﬁcant. The presence of both the
IGF2BP2 risk allele and exposure to famine associated
with lower AUC for glucose, which seems counterintuitive
considering the main effects of the two factors, which are
both associated with increased type 2 diabetes risk. How-
ever, a similar interaction was observed in two other
studies on the effect of a genetic variant in the ACE gene
(6,7). Subjects carrying the ACE risk allele were rela-
tively protected from the effect of low birth weight on
insulin resistance (6,7). These ﬁndings together with the
current ﬁnding on IGF2BP2 may be explained by over-
efﬁcient modulating effects of risk alleles during fetal
development. This would imply that the IGF2BP2 vari-
ant, being part of an important developmental pathway,
confers a relative resistance to the detrimental conse-
quences of fetal malnutrition on glucose tolerance at an
adult age.
IGF2BP2, also referred to as IMP-2, is an mRNA-binding
protein that posttranslationally regulates IGF2, a fetal
growth factor, during several developmental stages (22).
IGF2 plays a critical role during placental and fetal devel-
opment (23,24). IGFBPs have a tissue-speciﬁc expression
pattern, with IGF2BP2 being expressed in fetal lung,
kidney, thymus, and placenta and having its highest
expression in fetal liver (22). Interactions between
genetic variation in IGF2BP2 and fetal malnutrition may
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1442 DIABETES, VOL. 58, JUNE 2009However, such explanations are fully speculative, and it
is important to stress that our observation was no
longer signiﬁcant after correcting for multiple testing
and should therefore be interpreted with caution. None-
theless, it may suggest that consequences of the fetal
environment depend on an individual’s genetic back-
ground. Interactions of other variants investigated may
unfortunately not have become apparent due to the
limited power of our study.
None of the polymorphisms was associated with birth
weight. This is not in line with the fetal insulin hypothesis,
which proposes that the same genetic factors would alter
both intrauterine growth and adult glucose metabolism
(25). The TCF7L2 gene has consistently been associated
with birth weight (26). Unfortunately, we do not have
maternal genotypes available. Mother-child pair analyses
suggest that the TCF7L2 variant effect on birth weight
is a reﬂection of its presence in the mother (26). In
conclusion, genetic variants involved in fetal develop-
ment, like IGF2BP2, may inﬂuence the response to fetal
malnutrition and its consequences in the adult hyperca-
loric environment.
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FIG. 1. The effect of the IGF2BP2 genotypes on AUC glucose
according to prenatal exposure to famine. Number of subjects shown
inside of each bar, SEs of the mean shown on top of each bar. u, GG;
f, GT; , TT.
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